Literature DB >> 33413089

Modeling drug mechanism of action with large scale gene-expression profiles using GPAR, an artificial intelligence platform.

Shengqiao Gao1, Lu Han1, Dan Luo1, Gang Liu1, Zhiyong Xiao1, Guangcun Shan2, Yongxiang Zhang3, Wenxia Zhou4.   

Abstract

BACKGROUND: Querying drug-induced gene expression profiles with machine learning method is an effective way for revealing drug mechanism of actions (MOAs), which is strongly supported by the growth of large scale and high-throughput gene expression databases. However, due to the lack of code-free and user friendly applications, it is not easy for biologists and pharmacologists to model MOAs with state-of-art deep learning approach.
RESULTS: In this work, a newly developed online collaborative tool, Genetic profile-activity relationship (GPAR) was built to help modeling and predicting MOAs easily via deep learning. The users can use GPAR to customize their training sets to train self-defined MOA prediction models, to evaluate the model performances and to make further predictions automatically. Cross-validation tests show GPAR outperforms Gene set enrichment analysis in predicting MOAs.
CONCLUSION: GPAR can serve as a better approach in MOAs prediction, which may facilitate researchers to generate more reliable MOA hypothesis.

Entities:  

Keywords:  Deep learning; Gene expression profiles; L1000; MOA

Mesh:

Substances:

Year:  2021        PMID: 33413089      PMCID: PMC7788535          DOI: 10.1186/s12859-020-03915-6

Source DB:  PubMed          Journal:  BMC Bioinformatics        ISSN: 1471-2105            Impact factor:   3.169


  34 in total

1.  Gene expression inference with deep learning.

Authors:  Yifei Chen; Yi Li; Rajiv Narayan; Aravind Subramanian; Xiaohui Xie
Journal:  Bioinformatics       Date:  2016-02-11       Impact factor: 6.937

Review 2.  Deep learning.

Authors:  Yann LeCun; Yoshua Bengio; Geoffrey Hinton
Journal:  Nature       Date:  2015-05-28       Impact factor: 49.962

3.  Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy.

Authors:  Nehme El-Hachem; Deena M A Gendoo; Laleh Soltan Ghoraie; Zhaleh Safikhani; Petr Smirnov; Christina Chung; Kenan Deng; Ailsa Fang; Erin Birkwood; Chantal Ho; Ruth Isserlin; Gary D Bader; Anna Goldenberg; Benjamin Haibe-Kains
Journal:  Cancer Res       Date:  2017-03-17       Impact factor: 12.701

4.  GeneExpressionSignature: an R package for discovering functional connections using gene expression signatures.

Authors:  Fei Li; Yang Cao; Lu Han; Xiuliang Cui; Dafei Xie; Shengqi Wang; Xiaochen Bo
Journal:  OMICS       Date:  2013-02

5.  Drug-induced adverse events prediction with the LINCS L1000 data.

Authors:  Zichen Wang; Neil R Clark; Avi Ma'ayan
Journal:  Bioinformatics       Date:  2016-04-01       Impact factor: 6.937

6.  Drug-induced regulation of target expression.

Authors:  Murat Iskar; Monica Campillos; Michael Kuhn; Lars Juhl Jensen; Vera van Noort; Peer Bork
Journal:  PLoS Comput Biol       Date:  2010-09-09       Impact factor: 4.475

7.  Mantra 2.0: an online collaborative resource for drug mode of action and repurposing by network analysis.

Authors:  Diego Carrella; Francesco Napolitano; Rossella Rispoli; Mario Miglietta; Annamaria Carissimo; Luisa Cutillo; Francesco Sirci; Francesco Gregoretti; Diego Di Bernardo
Journal:  Bioinformatics       Date:  2014-02-20       Impact factor: 6.937

8.  A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.

Authors:  David R Boulware; Matthew F Pullen; Ananta S Bangdiwala; Katelyn A Pastick; Sarah M Lofgren; Elizabeth C Okafor; Caleb P Skipper; Alanna A Nascene; Melanie R Nicol; Mahsa Abassi; Nicole W Engen; Matthew P Cheng; Derek LaBar; Sylvain A Lother; Lauren J MacKenzie; Glen Drobot; Nicole Marten; Ryan Zarychanski; Lauren E Kelly; Ilan S Schwartz; Emily G McDonald; Radha Rajasingham; Todd C Lee; Kathy H Hullsiek
Journal:  N Engl J Med       Date:  2020-06-03       Impact factor: 91.245

9.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.

Authors:  Manli Wang; Ruiyuan Cao; Leike Zhang; Xinglou Yang; Jia Liu; Mingyue Xu; Zhengli Shi; Zhihong Hu; Wu Zhong; Gengfu Xiao
Journal:  Cell Res       Date:  2020-02-04       Impact factor: 25.617

10.  Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data.

Authors:  Alexander Aliper; Sergey Plis; Artem Artemov; Alvaro Ulloa; Polina Mamoshina; Alex Zhavoronkov
Journal:  Mol Pharm       Date:  2016-06-08       Impact factor: 4.939

View more
  2 in total

1.  Accelerating drug repurposing for COVID-19 treatment by modeling mechanisms of action using cell image features and machine learning.

Authors:  Lu Han; Guangcun Shan; Bingfeng Chu; Hongyu Wang; Zhongjian Wang; Shengqiao Gao; Wenxia Zhou
Journal:  Cogn Neurodyn       Date:  2021-11-05       Impact factor: 5.082

Review 2.  Computational analyses of mechanism of action (MoA): data, methods and integration.

Authors:  Maria-Anna Trapotsi; Layla Hosseini-Gerami; Andreas Bender
Journal:  RSC Chem Biol       Date:  2021-12-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.